We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Forest Labs’ Bystolic Heart Drug Turned Down by Committee
Forest Labs’ Bystolic Heart Drug Turned Down by Committee
January 15, 2010
An FDA advisory panel voted 8–0 to withhold a recommendation for Forest Laboratories’ hypertension drug Bystolic to treat heart failure.